Basic Information
Basic information for LINC00342-210-31aa
Peptide Name LINC00342-210-31aa
Genome Position chr2:95807133-95807225[-]
Species Human
Peptide Sequence MLTRLVLNSWHPSDPFAWNPKVSDLLKNISL
Peptide Length 31
Unique No (LINC00342-201-31aa,LINC00342-202-31aa-1,AC092683.1-203-31aa,AC092683.1-204-31aa-3,AC159540.2-203-31aa,AC159540.2-202-31aa-3,AC092683.1-206-31aa,AC159540.2-207-31aa-1,AC092683.1-205-31aa,AC159540.2-206-31aa,AC092683.1-202-31aa,AC159540.2-201-31aa,AC092683.1-201-31aa-1,AC092683.1-221-31aa,LINC00342-203-31aa,AC092683.1-219-31aa,AC159540.2-205-31aa-3,AC092683.1-218-31aa,AC092683.1-220-31aa-1,LINC00342-204-31aa,LINC00342-205-31aa,LINC00342-206-31aa-2,LINC00342-207-31aa-3,LINC00342-208-31aa-1,LINC00342-211-31aa-1,LINC00342-212-31aa-2,LINC00342-213-31aa)
Grand Average of Hydropathicity -0.0419
Relative Molecular Mass 4133.63
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000232931;LINC00342
Transcript ID/Name ENST00000662121;LINC00342-210
Transcript Length 879
Coding Ability 0.4858
DNA Sequence Corresponding to Peptide ATGTTGACCAGGCTGGTCTTGAACTCTTGGCACCCAAGCGATCCTTTTGCCTGGAATCCCAAAGTGTCAGATTTACTGAAGAATATTTCATTG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :